Medical device and MedTech insights, news, tips and more

Corindus Vascular Robotics hires J. Aaron Grantham as chief medical officer 

August 8, 2016

Corindus Vascular Robotics

Corindus Vascular Robotics announced August 3 that it had hired J. Aaron Grantham, MD, as its chief medical officer.

Corindus Vascular Robotics

Grantham, an interventional cardiologist, will continue to treat patients at Saint Luke’s Mid America Heart Institute in Kansas City, Missouri.

In his new role at Corindus, Grantham will focus on educating physicians and others about the benefits of robotic therapy and develop clinical data to support expanded indications for the company’s CorPath system.

The FDA has granted the CorPath system 510(k) clearance for use during PCIs and peripheral vascular interventions.

Mark J. Toland, a former Boston Scientific executive, became Corindus’s CEO and president in February. Two other executives joined Corindus this spring: Doug Teany as senior vice president of research and development and operations and Nora Dutta as vice president of human resources.

In May, researchers presented a prospective analysis at the Society for Cardiovascular Angiography and Interventions scientific sessions that found that patients had similar outcomes if they underwent a manual PCI or robotically assisted PCI with the CorPath system.

Source: Corindus hires J. Aaron Grantham as chief medical officer | Cardiovascular Business

Author: Tim Casey

Photo Credit: Business Wire

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.